Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Immune Checkpoint Inhibitors, Cardiotoxicity

Interventions

DIAGNOSTIC_TEST

Cardiac magnetic resonance

Cardiac magnetic resonance protocols include cine, non-contrast T1-mapping and T2-mapping.

Trial Locations (1)

RECRUITING

West China Second University Hospital, Chengdu

All Listed Sponsors

lead

West China Second University Hospital

OTHER